Application
ACSM2A Antibody (N-term) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the ACSM2A antibody detected the ACSM2A protein (arrow).| Product Name | ACSM2A Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ACSM2A; ACSM2; MACS2; Acyl-coenzyme A synthetase ACSM2A, mitochondrial; Acyl-CoA synthetase medium-chain family member 2A; Butyrate--CoA ligase 2A; Butyryl-coenzyme A synthetase 2A; Middle-chain acyl-CoA synthetase 2A |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | ACSM2 MACS2 |
|---|---|
| Alternative Names | ACSM2A ACSM2 MACS2 Acyl-coenzyme A synthetase ACSM2A mitochondrial Acyl-CoA synthetase medium-chain family member 2A Butyrate--CoA ligase 2A Butyryl-coenzyme A synthetase 2A Middle-chain acyl-CoA synthetase 2A |
| Molecular Weight(MW) | 64223 Da |
| Function | Has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4- unsaturated acids (in vitro) (By similarity) |
| Tissue Specificity | This ACSM2A antibody is generated from rabbits immunized with a KLH conjugated synthetic between 40-67 amino acids selected from the N-terminal region of human ACSM2A. |
| Cellular Localization | Mitochondrion matrix (By similarity). |
| Entrez Gene | 123876 |
|---|---|
| Nucleotide Accession | NP_001010845.1 |
Application
ACSM2A Antibody (N-term) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the ACSM2A antibody detected the ACSM2A protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
